The opportunity to save lives and improve patient care is global in scale with immense societal impact. There are 48.9 million sepsis cases and 11 million sepsis-related deaths as a result of organ failure worldwide each year. One person in the world dies every three seconds from organ failure related to sepsis, accounting for 20% of all deaths globally. Others survive only to endure prolonged periods of critical illness and dependency on vital organ support. The financial burden of treating sepsis costs the U.S. healthcare system alone nearly $25 billion dollars annually.*
Preventing Organ Failure Through Early Detection
Delayed Treatment Costs Lives
Opticyte is transforming the standard of care for the leading causes of organ failure, including sepsis, with real-time measurement.
The Need is Now for Definitive, Actionable Oximetry Data
Every minute counts when a patient’s organs aren’t receiving enough oxygen. Today’s technology, including pulse oximeters, fails to provide clinicians with definitive, real-time information that can be used to prevent organ failure. Current methods for diagnosis rely on indirect indicators of cellular oxygen levels that are often too delayed, ambiguous or inaccurate to help clinicians determine the correct dose and timing of treatment.
With Opticyte’s Cell O₂ Monitor, clinicians can immediately respond to a patient’s urgent medical condition with confidence to prevent irreversible organ damage and failure.
The World’s Only
Cell O₂ Monitor
The Opticyte Cell O₂ Monitor leverages proprietary advanced algorithms, tailored optical spectroscopy technology, and a functional, form-fitting disposable sensor to continuously measure oxygen levels inside cells in real time. The world’s first cellular oxygen monitor provides clinicians immediate, actionable insights related to organ oxygen deficiency caused by sepsis, internal bleeding, and other serious health conditions. Oxygen levels are measured where it matters most, inside cells – not in the bloodstream like current oximeters.
Engineered for Care Providers in:
COVID-19: Seeing a New Solution to Future Patient Care
The Opticyte Cell O₂ Monitor offers a new potential sightline into care for COVID-19 patients. Published case studies tracking patients with severe COVID-19 reported septic shock severe enough to require drugs to support the heart and circulation in almost 70% of patients. Utilizing the Opticyte Cell O₂ Monitor offers the potential for clinicians and researchers to access real-time, definitive data to optimize patient care decisions in the future.